303 related articles for article (PubMed ID: 11263172)
41. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
Clark MK; Sowers MR; Nichols S; Levy B
Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
[TBL] [Abstract][Full Text] [Related]
42. Recent experience with and future directions of contraceptive implants and injectable contraceptives.
Alvarez-Sanchez F; Brache V; Faundes A
Curr Opin Obstet Gynecol; 1993 Dec; 5(6):805-14. PubMed ID: 8286694
[TBL] [Abstract][Full Text] [Related]
43. Statement on injectable contraception.
International Planned Parenthood Federation IPPF
IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
[TBL] [Abstract][Full Text] [Related]
44. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: final results.
Grossman RA; Asawasena W; Chalpati S; Taewtong D; Tovanabutra S
Bull World Health Organ; 1979; 57(5):829-37. PubMed ID: 161523
[TBL] [Abstract][Full Text] [Related]
45. Current options for injectable contraception in the United States.
Kaunitz AM
Semin Reprod Med; 2001 Dec; 19(4):331-7. PubMed ID: 11727175
[TBL] [Abstract][Full Text] [Related]
46. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
[TBL] [Abstract][Full Text] [Related]
47. [Effect of pretreatment counseling on discontinuation rates in women given depo-medroxyprogesterone acetate for contraception].
Lei Z; Wu S; Garceau RJ
Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):350-3. PubMed ID: 9596915
[TBL] [Abstract][Full Text] [Related]
48. Study of medroxyprogesterone: a long-acting injectable female contraceptive agent.
Ahmad G; Rasul A
Pak J Med Res; 1970 Jan; 9(1):46-9. PubMed ID: 12255593
[TBL] [Abstract][Full Text] [Related]
49. Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders.
Keder LM; Rulin MC; Gruss J
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):583-5. PubMed ID: 9757955
[TBL] [Abstract][Full Text] [Related]
50. Facts about injectable contraception.
Contracept Rep; 1994 Mar; 5(1):1-2. PubMed ID: 12287737
[TBL] [Abstract][Full Text] [Related]
51. [Community-based distribution of injectable contraceptives in an African setting: community trial in Madagascar].
Brunie A; Hoke TH; Razafindravony B
Sante; 2011; 21(1):21-6. PubMed ID: 21550921
[TBL] [Abstract][Full Text] [Related]
52. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
Gray RH; Parker RA; Diethelm P
Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
[TBL] [Abstract][Full Text] [Related]
53. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya.
Ruminjo JK; Sekadde-Kigondu CB; Karanja JG; Rivera R; Nasution M; Nutley T
Contraception; 2005 Aug; 72(2):138-45. PubMed ID: 16022854
[TBL] [Abstract][Full Text] [Related]
54. Comparison of two strategies for the administration of injectable depot medroxyprogesterone acetate: among women who returned to a family planning clinic at three- or six-month intervals.
Ferreira JM; Bottura BF; Gonçalves MP; Monteiro I; Bahamondes L
Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):408-11. PubMed ID: 27530899
[TBL] [Abstract][Full Text] [Related]
55. Vaginal estrogen supplementation during Depo-Provera initiation: a randomized controlled trial.
Dempsey A; Roca C; Westhoff C
Contraception; 2010 Sep; 82(3):250-5. PubMed ID: 20705153
[TBL] [Abstract][Full Text] [Related]
56. Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
Sereepapong W; Chotnopparatpattara P; Taneepanichskul S; Markham R; Russell P; Fraser IS
Hum Reprod; 2004 Mar; 19(3):547-52. PubMed ID: 14998949
[TBL] [Abstract][Full Text] [Related]
57. [Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland].
Lech MM
Wiad Lek; 2003; 56(7-8):362-8. PubMed ID: 14969166
[TBL] [Abstract][Full Text] [Related]
58. Contraceptive efficacy and safety of DMPA-SC.
Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
[TBL] [Abstract][Full Text] [Related]
59. Same-day administration of depot-medroxyprogesterone acetate injection: a retrospective chart review.
Balkus J; Miller L
Contraception; 2005 May; 71(5):395-8. PubMed ID: 15854642
[TBL] [Abstract][Full Text] [Related]
60. Hormones and weight change.
Pelkman C
J Reprod Med; 2002 Sep; 47(9 Suppl):791-4. PubMed ID: 12380408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
